[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Northwest Biothrputcs Inc (NWBO)

Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 289,842
  • Shares Outstanding, K 1,688,074
  • Annual Sales, $ 1,380 K
  • Annual Income, $ -60,160 K
  • EBIT $ -71 M
  • EBITDA $ -67 M
  • 60-Month Beta -0.63
  • Price/Sales 207.15
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -18.23
  • Most Recent Earnings $0.00 on 05/15/26
  • Next Earnings Date 08/13/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1411 +21.69%
on 07/16/26
0.1990 -13.72%
on 07/06/26
-0.0174 (-9.20%)
since 06/24/26
3-Month
0.1411 +21.69%
on 07/16/26
0.2999 -42.75%
on 05/12/26
-0.0311 (-15.34%)
since 04/24/26
52-Week
0.1411 +21.69%
on 07/16/26
0.3680 -53.34%
on 08/28/25
-0.0783 (-31.32%)
since 07/24/25

Most Recent Stories

More News
Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses

Scientific Presentation at British Neuro-Oncology Annual Meeting Shows Original Analysis of   Survival Extension Was Likely Underestimated

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting

BETHESDA, Md. , July 2, 2026 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform

BETHESDA, Md. , April 30, 2026 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic

BETHESDA, Md. , April 21, 2026 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility

BETHESDA, Md. , Nov. 20, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed

BETHESDA, Md. , Oct. 24, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Settles Litigation Over Option Awards

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Northwest...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.

BETHESDA, Md. , Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman

BETHESDA, Md. , Aug. 18, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies...

NWBO : 0.1717 (+1.54%)
Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Both %ShuttlePharmaceuticals (Nasdaq: $SHPH) and %NorthwestBiotherapeutics (OTC: $NWBO) are companies that have attracted investor attention due to their promising %Cancer treatments. Both have relatively...

NWBO : 0.1717 (+1.54%)
MRK : 131.07 (+0.45%)
SHPH : 2.89 (-3.34%)
BMY : 62.09 (+0.94%)

Business Summary

Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.

See More

Key Turning Points

3rd Resistance Point 0.1803
2nd Resistance Point 0.1772
1st Resistance Point 0.1744
Last Price 0.1717
1st Support Level 0.1685
2nd Support Level 0.1654
3rd Support Level 0.1626

See More

52-Week High 0.3680
Fibonacci 61.8% 0.2813
Fibonacci 50% 0.2546
Fibonacci 38.2% 0.2278
Last Price 0.1717
52-Week Low 0.1411

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.